Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.210
+0.020 (0.63%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Niagen Bioscience Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 130.42 | 129.42 | 99.6 | 83.57 | 72.05 | 67.45 |
Revenue Growth | 20.84% | 29.95% | 19.18% | 15.99% | 6.82% | 13.83% |
Gross Profit Gross Profit Growth | 83.83 | 83.19 | 61.59 | 50.78 | 42.8 | 41.49 |
Operating Income Operating Income Growth | 11.1 | 12.31 | 7.73 | -5.6 | -18.63 | -27.07 |
Net Income Net Income Growth | 18.64 | 17.38 | 8.55 | -4.94 | -16.54 | -27.13 |
Earnings Per Share EPS Growth | 0.21 | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
EPS Growth | 18.45% | 81.82% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Ingredients Ingredients Growth | 29.07 | 28.68 | 19.81 | 11.14 | 8.74 | 7.41 |
Analytical Reference Standards and Services Analytical Reference Standards and Services Growth | 2.69 | 3.08 | 3.01 | 2.91 | 3.2 | 3.34 |
Consumer Products Consumer Products Growth | 98.58 | 97.67 | 76.77 | 69.53 | 60.11 | 56.71 |
Total Total Growth | 130.42 | 129.42 | 99.6 | 83.57 | 72.05 | 67.45 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 66.55 | 64.79 | 44.66 | 27.33 | 20.44 | 28.22 |
Total Debt Total Debt Growth | 2.58 | 2.82 | 2.65 | 3.28 | 4.26 | 4.7 |
Net Cash (Debt) Net Cash Growth | 63.97 | 61.97 | 42.01 | 24.05 | 16.18 | 23.52 |
Net Cash Growth | 22.81% | 47.52% | 74.69% | 48.59% | -31.18% | 56.16% |
Net Cash Per Share Net Cash Per Share Growth | 0.75 | 0.73 | 0.54 | 0.32 | 0.23 | 0.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4.43 | 13.5 | 12.11 | 7.12 | -15.1 | -24.16 |
Capital Expenditures CapEx Growth | -0.32 | -0.29 | -0.16 | -0.15 | -0.33 | -0.41 |
Free Cash Flow Free Cash Flow Growth | 4.11 | 13.21 | 11.95 | 6.97 | -15.43 | -24.57 |
Free Cash Flow Growth | -78.99% | 10.60% | 71.42% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.28% | 64.28% | 61.84% | 60.76% | 59.40% | 61.51% |
Operating Margin | 8.51% | 9.51% | 7.76% | -6.70% | -25.85% | -40.14% |
Pretax Margin | 13.75% | 12.47% | 10.02% | -5.91% | -22.96% | -40.22% |
Profit Margin | 12.93% | 11.84% | 9.72% | -5.91% | -22.96% | -40.22% |
FCF Margin | 3.15% | 10.21% | 11.99% | 8.34% | -21.42% | -36.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.28 | 31.80 | 48.27 | - | - | - |
Forward PE | 16.89 | 27.81 | 50.28 | 160.00 | 160.00 | 160.00 |
P/FCF Ratio | 62.40 | 38.37 | 34.37 | 15.39 | - | - |
PS Ratio | 1.96 | 3.92 | 4.12 | 1.28 | 1.74 | 3.78 |